Document (7)
Document (7)
Introduction-
• According to USP, Tablet is defined as a compressed solid dosage form
containing medicaments with or without Excipients.
• According to the Indian Pharmacopoeia, Tablets are solid, flat, unit dosage
form, prepared by compressing a mixture of drug and excipients with or
without diluents.
TABLETS
Types of tablets-
a. Tablets ingested orally:
➢ Compressed tablets
➢ Multiple compressed tablets
➢ Enteric coated tablet
➢ Film coated tablets
➢ Chewable tablets
b. Tablets used in oral cavities:
➢ Buccal Tablets
➢ Sublingual Tablets
➢ Lozenges
➢ Dental cones
Multilayered tablets
iii. Enteric coated tablets:
• These are compressed tablet meant for administration by
swallowing and are designed to by- pass the stomach and get
disintegrated in the intestine only.
• These tablets are coated with materials resistant to acidic pH (like
cellulose acetate phthalate, CAP) of the gastric fluid but
disintegrate in the alkaline pH of the intestine.
Sublingual tablets
3) Lozenges Tablets:
❖ These tablets are designed to exert a local effect in the mouth or
throat. These tablets are commonly used to treat sore throat to
control coughing in common cold. They may contain local
anaesthetics , antiseptics, antibacterial agents and astringents.
❖ These are prepared by compression at high pressure by the moulding
process and generally contain a sweetening agent, flavouring agent
and a substance which roduces a cooling effect.
Vicks lozenges, Strepsils.
4) Dental cones:
▪ These are compressed tablets meant for placement in the empty
sockets after tooth extraction. They prevent the multiplication of
bacteria in the socket.
▪ These tablets contain an excipient like lactose, sodium bicarbonate
and sodium chloride. These cones generally dissolved in 20 to 40
minutes time.
Dental cones
Function of excipients-
➢ Impart weight, accuracy, & volume.
➢ Improve solubility.
➢ Increase stability
➢ Enhance bioavailability
➢ Modifying drug release
➢ Assist product identification
➢ Increase patient acceptability
➢ Facilitate dosage form design
1. Diluents
Diluents are filler used to make required bulk of tablet when the drug dosage
itself is inadequate to produce the bulk.
Characteristics of binder
Method-1
• Binders are used in dry form in the powder and then moistened with a
solvent to form wet lumps.
Method- 2
• Binders are often added in solution form. It requires lower concentration of
binder.
• By method- 1 the binder is not as effective in reaching and wetting each of
the particles within the mass of the powder. Each of the particle in a powder
blend has a coating of absorbed air on its surface, and it is this film of air
which must be penetrate before the powder can be wetted by the binder
solution.
Method- 3
• In direct compression method MCC, microcrystalline dextrose, amylose and
PVP are used- those have good flow property and cohesiveness as well.
• It has been postulated that MCC is a special from of cellulose fibril in
which individual crystallites are held together largely by hydrogen bonding.
The disintegration of tablets containing the cellulose occurs by breaking
intercrystallite bonds by the disintegrating medium.
3. Disintegrants
A disintegrant is a substance to a mixture of substances, added to tablet to
facilitate its breakup or disintegration after administration in the GIT. The
active ingredients must be released from the tablet matrix as efficiently as
possible to allow for its rapid dissolution.
Starch
• Corn starch, potato starch.
• For their disintegrating effect starches are added to the powder
blends in dry state.
Mode of action:
• Starch has a great affinity for water and swells when moistened, thus
facilitating the rupture of the tablet matrix.
• Others have suggested that the spherical shape of the starch grains
increase the porosity of the tablet, thus promoting capillary action.
• Normally 5% w/w is suggested and for rapid disintegration 10-15% w/w
may be taken.
Objectives:
• Prevents adhesion of the tablet material to the surface of dies and
punches.
• Reduce inter-particular friction, improve the rate of flow of tablet
granulation.
• Facilitate ejection of the tablets from the die cavity.
5. Colouring agent
Granulation Technology-
Granulation: It is the process in which primary powder particles are made to
adhere to form large multi-particle entities.
Range of size:0.2mm to 4mm.
Objectives:-
➢ To enhance the flow of powder.
➢ To produce dust free formulations and produce uniform mixtures.
➢ To improve compaction characteristics.
➢ To eliminate poor content uniformity of mixture.
➢ To avoid powder segregation. As Segregation may result in weight
variation.
Percolation Segregation:- Air void
Trajectory Segregation:- Kinetic energy
There are two methods of granulation:
1. Wet granulation.
2. Dry granulation.
Wet Granulation-
Granulation is a critical process for transforming powders into uniform, free-
flowing granules, which are then compressed into tablets.
Tablet Preparation by Wet Granulation:-
1. Mixing: Combine the active pharmaceutical ingredient with
excipients.
2. Granulation: Add a granulating liquid to the powder mix to form a
wet mass.
3. Screening: Pass the wet mass through a screen to produce
granules.
4. Drying: Dry the granules using a fluid bed dryer or tray dryer.
5. Milling: Mill the dry granules to a uniform size.
6. Blending: Blend the granules with lubricants and disintegrants.
7. Compression: Compress the blend into tablet press.
APIs + Excipients
Mixing/Blending
Granulation (wet
granulation)
Milling
Tableting
Coating
Dry granulation:-
Dry granulation is the process of forming particles-i.e., granulates or granules
from dry powder or powder blend without adding liquid to aid in the process.
The powdered solids are mixed and then pressed into flat-faced large-sized tablets
(slugs) on a conventional tablet press. The process is performed without using heat
or solvents. Then, the slugs are milled into granules.
Dry granulation steps:-
Steps of the slugging process
❖ A powder blend is fed into a tablet press.
❖ The blend is compressed into extra large tablets or slugs using flat-faced
punches.
❖ The slugs are subjected to screening both before and after the slugging
procedure.
❖ The slugs are then broken down into the desired particle size by a hammer
mill or an oscillating granulator.
❖ The milled particles are screened to form the final granules.
Tablet compression
It can reduce the volume by apply pressure, particle in die are re-arrange, resulting
a closer packing structure and reduce space and at certain lode reduce space and
increase inter-particulate friction will prevent farther interparticulate friction.
Detection: Subjecting tablets to the friability test is the quickest way to reveal such
problems.
Remedies:
1. Lettering should be designed as large as possible, particularly
on punches of small diameter.
2. Plating of the punch faces with chromium produces smooth, non-
adherent face.
3. Colloidal Silica is added as polishing agent that makes the
punch faces smooth; so that material does not cling to them.
Mottling
Mottling is an unequal distribution of colour on a tablet, with light or dark patches
in an otherwise uniform surface.
These factors must be controlled during production and verified after production,
hence called In-process control.
Weight Variation:-
This test is based on the fact that, if the weight variation is within the limits then it
can be said that the amount of medicament will uniform considerably. Conversely,
if the weight variation is not in limits then it can be concluded that the active
medicament will uniform considerably.
Sources of weight variation
Weight variation is solely dependent on the poor flow property of granules and
filling of die cavity. Poor flow properties arise from:
a) Improper lubrication
b) Size of granules
c) Adjustment of lower punch
Weight variation test
The U.S.P weight variation test is run by weighing 20 tablets individually,
calculating the average weight, and comparing the individual tablet weights to the
average. The tablets meet the USP test if ‘not more than 2 tablets are outside the
percentage limit and if no tablet differ by more than 2 times the percentage limit.’
Dissolution test:-
• Disintegration test simply identifies the time required for the tablet to break
up under the condition of the test but it does not ensure the drug release in
the bulk of the fluid.
• Rate of dissolution is directly related to the efficacy of the drug. Rate of
dissolution is a good index for comparing the bioavailability of two tablet
products of the same drug.
Apparatus-1 (Basket):-
➢ In general, a single tablet is placed in a small wire mesh basket and
immersed in the dissolution medium contained in a 1000ml flask at 37
Degree Celsius. Generally it is rotated at 50 rpm unless otherwise specified.
Apparatus-2 (Paddle):-
➢ The same equipment is used. Instead of a paddle is introduced as the stirring
element. The tablet is allowed to sink at the bottom of the flask before
stirring.
➢ Limit: A value of t90% (i.e 90% drug release) within 30 minutes is often
considered satisfactory and is an excellent goal since a common dissolution
tolerance in the USP/NF is not less than 75% dissolved in 45 minutes.
Tablet Hardness:-
The resistance of the tablet to chipping, abrasion or breakage under conditions of
storage, transportation and handling before usage depends on its hardness.
Method:
A tablet is taken between the 2nd and 3rd finger and pressing it with the thumb as
fulcrum. If the tablet breaks with a ‘sharp snap', yet, it does not break when it falls
on the floor- is said to possess proper hardness.
Instruments used:
a) Monsanto harness tester
b) Strong Cobb Hardness Tester- Manual mode.
Hardness of a tablet:
The hardness at which the tablet crushes is the harness of the tablet.
• Unit of hardness : Kg/sq.in. or lb/sq.in
• Limit: Generally maximum 5 kg/sq.in. hardness is required.
Friability:-
Tablet hardness is not an absolute indicator of strength since some formulation,
when compressed into very hard tablets may produce chipping, capping and
lamination problems. Therefore, another measure of tablet strength i.e. friability is
often measured, i.e. the friability.